Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]]
| Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]] |
| Pubbl/distr/stampa | London : , : RCOG Press, , 2010 |
| Descrizione fisica | 1 online resource (ix, 227 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN |
1-107-71102-9
1-107-71445-1 9786613269065 1-283-26906-6 1-906985-51-0 1-107-47834-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910463266103321 |
| London : , : RCOG Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]]
| Current management of polycystic ovary syndrome / / edited by Adam Balen [and others] [[electronic resource]] |
| Pubbl/distr/stampa | London : , : RCOG Press, , 2010 |
| Descrizione fisica | 1 online resource (ix, 227 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN |
1-107-71102-9
1-107-71445-1 9786613269065 1-283-26906-6 1-906985-51-0 1-107-47834-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910787985103321 |
| London : , : RCOG Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current management of polycystic ovary syndrome / / edited by Adam H. Balen ...[et. al.]
| Current management of polycystic ovary syndrome / / edited by Adam H. Balen ...[et. al.] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London, : RCOG, 2010 |
| Descrizione fisica | 1 online resource (ix, 227 pages) : digital, PDF file(s) |
| Disciplina | 618.1/1 |
| Altri autori (Persone) | BalenAdam H |
| Soggetto topico |
Polycystic ovary syndrome
Ovaries - Cysts |
| ISBN |
1-107-71102-9
1-107-71445-1 9786613269065 1-283-26906-6 1-906985-51-0 1-107-47834-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title page -- Contents -- Participants -- Additional contributors -- Declarations of personal interest -- Preface -- 1 Overview and definitions of polycystic ovary syndrome and the polycystic ovary -- Introduction -- What is polycystic ovary syndrome? -- Defining the polycystic ovary: historical and histopathological considerations -- Ultrasound descriptions of the polycystic ovary -- Multicystic and polycystic ovaries -- Transvaginal ultrasound -- Stromal echogenicity -- Three-dimensional ultrasound, Doppler and MRI -- Exclusion of related disorders -- Conclusion -- Key points -- References -- 2 Genetics and pathogenesis of polycystic ovary syndrome -- Introduction -- Developmental origin of PCOS -- Genes and PCOS -- Role of the intrauterine environment -- Role of the external environment: diet, obesity and PCOS -- Summary -- References -- 3 Ethnic variations in the expression of polycystic ovary syndrome -- Introduction -- Defining race and ethnicity -- Evidence for ethnic variations in the expression of PCOS -- Historical background -- Ethnic variations of obesity, insulin resistance and the metabolic syndrome in PCOS -- The Asian perspective -- Non-Asians -- Ethnic variation of hyperandrogenism in PCOS -- East Asians -- Other ethnic groups -- Ethnic interrelationships of metabolic problems and hyperandrogenism manifestations of PCOS -- Epidemiological variations of insulin resistance and the prevalence of PCOS - are they in parallel? -- Ethnic differences in diagnostic thresholds for polycystic ovaries -- Ethnic differences in quality of life -- Summary and conclusion -- Acknowledgements -- References -- 4 Quality of life for women with polycystic ovary syndrome -- Introduction -- What is health-related quality of life? -- Measuring HRQoL -- Types of instrument available to measure quality of life in women with PCOS.
Generic questionnaires -- Overall impact of PCOS on HRQoL -- Comparisons with controls (other gynaecological populations) -- PCOS and mental health -- Impact of PCOS-associated obesity on HRQoL -- Problems with proxy assessments of HRQoL -- Impact of PCOS-associated infertility and sexual functioning on HRQoL -- Treatments for PCOS that have measured associated changes to HRQoL -- Conclusion -- Summary of key points -- References -- 5 Insulin resistance, the metabolic syndrome and polycystic ovary syndrome -- Introduction -- Definitions and diagnosis -- Mechanism of insulin resistance in PCOS -- Interactions between the metabolic syndrome and ovarian function -- Insulin as a co-gonadotrophin -- Inflammation and the ovary -- PCOS as a marker for type 2 diabetes -- PCOS as a marker for cardiovascular disease -- PCOS and non-alcoholic steatohepatitis -- PCOS and implications for family members -- Treatment of PCOS and the metabolic syndrome -- Conclusion -- References -- 6 Management of polycystic ovary syndrome through puberty and adolescence -- Introduction -- Diagnosis -- The menstrual cycle during adolescence -- Ovarian appearance on ultrasound -- Hormonal changes during puberty -- Clinical presentation -- Developmental origins of PCOS -- Differential diagnosis -- Treatment -- Oral contraceptive pills -- Metformin -- Thiazolidinediones -- Antiandrogens -- Recommendations -- Clinical evaluation -- Investigations -- Treatment -- Monitoring -- Conclusion -- References -- 7 Long-term health risks of polycystic ovary syndrome -- Increased cardiovascular risk -- Surrogates for cardiovascular disease -- Traditional measures and the metabolic syndrome -- New markers -- Waist circumference and HDL cholesterol -- PCOS as a risk factor on its own -- Recommendations -- Risk for type 2 diabetes and impaired glucose tolerance -- Complications of obesity. Gynaecological malignancies -- Endometrial hyperplasia and cancer -- Breast cancer -- Ovarian cancer -- Conclusion -- References -- 8 Approaches to lifestyle management in polycystic ovary syndrome -- Introduction -- Prevalence of obesity and PCOS -- Evidence that early weight gain favours the development of PCOS -- Pathophysiological aspects of adipose tissue in PCOS -- Obesity worsens the PCOS phenotype and associated metabolic alterations -- Treatment of obesity improves PCOS -- Lifestyle management -- Lifestyle modification and infertility -- Conclusion -- References -- 9 Management of obesity in polycystic ovary syndrome, including anti-obesity drugs and bariatric surgery -- Introduction -- Lifestyle modification -- Anti-obesity medication -- Orlistat -- Sibutramine -- Bariatric surgery -- Background -- Bariatric surgery and PCOS -- Pregnancy after bariatric surgery -- Conclusion -- References -- 10 Definition of hyperandrogenism -- Clinical hyperandrogenism -- Biochemical hyperandrogenism -- Assessment of anovulation -- Proposal for new criteria -- Clinical hyperandrogenism -- Laboratory hyperandrogenism -- Laboratory diagnosis of anovulation -- Summary -- References -- 11 Treatment of hyperandrogenism in polycystic ovary syndrome -- Introduction -- Acne -- General advice -- Managing according to clinical sub-type -- Treatment of non-inflammatory lesions -- Treatment of mild to moderate inflammatory lesions -- Topical therapies for post-inflammatory hyperpigmentation -- Alternative therapies and procedures -- Nodular lesions -- Non-inflammatory lesions -- Skincare and use of cosmetics -- Systemic therapies -- Inhibitors of adrenal androgen production -- Inhibitors of ovarian androgen production -- Oral contraceptives -- Gonadotrophin-releasing hormone agonists -- Androgen receptor blockers -- Spironolactone -- Flutamide -- Finasteride. Insulin-sensitising drugs -- Conclusion on acne management in PCOS -- Hirsutism -- Topical therapy -- Eflornithine hydrochloride -- Systemic therapy -- COC pills -- Cyproterone acetate -- Spironolactone -- Gonadotrophin-releasing hormone agonists -- Finasteride -- Flutamide -- Insulin-sensitising drugs -- Female-pattern hair loss -- Minoxidil -- Antiandrogens -- Reductase inhibitors -- Conclusion -- References -- 12 Choices in the treatment of anovulatory polycystic ovary syndrome -- Introduction -- Weight loss -- Clomifene citrate -- Mode of action -- Dose -- Results -- Clomifene citrate treatment failure -- Monitoring -- Adjuvant treatment -- Aromatase inhibitors -- Mode of action -- Indications -- Dose -- Evidence -- Safety -- Metformin -- Mode of action -- Dose -- Evidence -- Safety -- Low-dose gonadotrophin therapy -- Principle -- Regimen -- Evidence -- Variations -- References -- 13 Predictors of ovarian response to ovarian stimulation: progress towards individualised treatment in ovulation induction -- Introduction -- Predictors of ovarian response in ovulation induction -- Predicting response to anti-estrogen therapy -- Predicting response to gonadotrophins -- Might genetic predictors be useful? -- Conclusion -- References -- 14 Surgical management of anovulatory infertility in polycystic ovary syndrome -- Introduction -- History -- Methods and dose -- Risks of adhesion formation and ovarian failure -- Endocrine changes after laparoscopic ovarian surgery -- Pregnancy rates -- Transvaginal approach -- Summary -- Key points -- Clinical practice points -- Future avenues for research -- References -- 15 The role of insulin-sensitising drugs in the treatment of polycystic ovary syndrome -- Introduction -- Metformin -- Premature pubarche -- Infertility -- Miscarriage and pregnancy complications -- Hirsutism -- Diabetes prevention. Endometrial cancer prevention -- Conclusion -- Acknowledgements -- References -- 16 The role of in vitro maturation of oocytes for anovulatory polycystic ovary syndrome -- In vitro maturation of immature oocytes -- Variations -- Patient selection -- hCG priming -- Gonadotrophin ovarian stimulation -- ICSI -- Endometrial priming -- Metformin co-treatment -- Timing of immature oocyte retrieval in relation to follicular diameter -- Results -- Safety -- Summary -- References -- 17 Acupuncture and/or herbal therapy as an alternative or complement for relief of polycystic ovary syndrome-related symptoms -- Introduction -- Treatment of PCOS -- The physiological basis for acupuncture -- How may acupuncture act in women with PCOS? -- Evidence for the use of acupuncture in PCOS -- Effects on ovulation -- Effects on metabolic abnormalities -- Effects on mental health -- Effects on the sympathetic nervous system -- Continuing or completed RCTs on the effects of acupuncture in PCOS-related symptoms -- Herbal therapy for the relief of PCOS-related symptoms -- Herbs for ovulation induction -- Vitex agnus-castus -- White peony -- Sairei-to -- Mentha spicata Labiatae -- Herbs for metabolic abnormalities -- Berberine -- Cinnamon -- Labisia pumila -- Future perspectives -- Conclusion -- References -- 18 Consensus views arising from the 59th Study Group: Current Management of Polycystic Ovary Syndrome -- Diagnosis/pathophysiology -- Management -- Lifestyle and metabolic aspects -- Treatments -- Research -- Index. |
| Record Nr. | UNINA-9910819029003321 |
| London, : RCOG, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Debatable Topics in PCOS Patients / / edited by N. K. Agrawal and Kiran Singh
| Debatable Topics in PCOS Patients / / edited by N. K. Agrawal and Kiran Singh |
| Pubbl/distr/stampa | Rijeka, Croatia : , : IntechOpen, , 2018 |
| Descrizione fisica | 1 online resource (120 pages) : illustrations some color |
| Disciplina | 618.1 |
| Soggetto topico |
Gynecology
Obstetrics Polycystic ovary syndrome |
| ISBN |
953-51-4048-5
953-51-3812-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317833903321 |
| Rijeka, Croatia : , : IntechOpen, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Impact of polycystic ovary, metabolic syndrome and obesity on women health . Volume 8 Frontiers in gynecological endocrinology / / Andrea R. Genazzani [and three others], editors
| Impact of polycystic ovary, metabolic syndrome and obesity on women health . Volume 8 Frontiers in gynecological endocrinology / / Andrea R. Genazzani [and three others], editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (227 pages) |
| Disciplina | 618.11 |
| Collana | ISGE Series |
| Soggetto topico |
Polycystic ovary syndrome
Metabolic syndrome Obesity Malalties de l'ovari Quistos Síndrome metabòlica Obesitat Ginecologia endocrina |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-63650-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- 1: The Brain Phenotype in Polycystic Ovary Syndrome (PCOS): Androgens, Anovulation, and Gender -- 1.1 Introduction -- 1.2 Anovulation Reflects the PCOS Brain Phenotype -- 1.3 Neuroregulation of GnRH and the Brain Phenotype in PCOS -- 1.4 Gender Identity and Sexual Orientation -- 1.5 Summary -- References -- 2: Adolescence: A High-Risk Period for PCOS Development? -- 2.1 The Role of Peri-Pubertal Obesity -- 2.2 Hyperandrogenism -- 2.3 GnRH Dysregulation -- 2.4 Brain Disorders -- 2.5 Endocrine-Disrupting Chemicals -- 2.6 Gut Microbiota -- 2.7 AMH -- 2.8 Conclusions -- References -- 3: Toward Adolescent Prevention of Adult Anovulation in Polycystic Ovary Syndrome -- 3.1 Definition, Origins, and Diagnosis of Adolescent PCOS -- 3.2 Treatment of Adolescent PCOS: Lifestyle, Estro-Progestagen, SPIOMET -- 3.3 SPIOMET Experience in Adolescent Girls: Limited but Promising -- 3.4 Perspective -- References -- 4: Environmental Factors Responsible for Obesity and Insulin Resistance in Polycystic Ovary Syndrome -- 4.1 Endocrine-Disrupting Chemicals -- 4.1.1 Bisphenol A -- 4.2 Advanced Glycation End Products -- 4.2.1 Vitamin D -- References -- 5: Pathogenesis of PCOS: From Metabolic and Neuroendocrine Implications to the Choice of the Therapeutic Strategy -- 5.1 Introduction -- 5.2 Physiopathology of the PCOS Patients -- 5.2.1 Weight and Metabolism -- 5.2.2 Hyperandrogenism -- 5.2.3 Insulin Resistance -- 5.3 New Perspectives in the Pathogenesis of PCOS -- 5.4 Genetics, Metabolism, and PCOS -- 5.5 The Management of Infertility in PCOS Patients -- 5.5.1 Lifestyle Modification -- 5.5.2 Bariatric Surgery -- 5.5.3 Metformin -- 5.5.4 Clomiphene Citrate -- 5.5.5 Letrozole -- 5.5.6 Ovarian Drilling -- 5.5.7 Gonadotropins and IVF -- 5.5.8 Inositols -- 5.5.9 Alpha-Lipoic Acid -- 5.6 Conclusions.
References -- 6: Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause -- 6.1 Introduction -- 6.2 Endocrine Profile of PCOS -- 6.3 Insulin Resistance (IR) and Compensatory Hyperinsulinism -- 6.4 How to Manage and What to Do in PCOS? -- 6.5 Estrogen-Progestin Preparations and PCOS -- 6.6 No Contraception but Let's Overcome Dysmetabolism! -- 6.7 Long-Term Consideration for PCOS! -- References -- 7: Impact of Polycystic Ovary Syndrome, Metabolic Syndrome, Obesity, and Follicular Growth Arrest in Women Health -- 7.1 Introduction -- 7.2 PCOS and Metabolic Syndrome Linkage -- 7.2.1 Insulin Resistance and Hyperinsulinism in PCOS -- 7.2.2 Role of Adipose Tissue in Insulin Resistance in PCOS -- 7.2.3 Role of Androgen in Insulin Resistance -- 7.3 Metabolic Syndrome, Hyperandrogenism, and Follicular Growth Arrest in PCOS -- 7.4 Intraovarian Mechanism of Follicular Growth Arrest in PCOS -- 7.5 Anti-Müllerian Hormone (AMH) and Follicular Growth Arrest -- 7.6 Dysregulation of Ovarian Angiogenesis and Estrogen Metabolites in the Follicular Growth Arrest -- 7.7 Conclusions -- References -- 8: Quality of Life and Sexual Health -- 8.1 Quality of Life -- 8.1.1 Hirsutism and Acne -- 8.1.2 Body Weight -- 8.1.3 Menstruation -- 8.1.4 Infertility -- 8.1.5 Psychological Distress (Depression and Anxiety) -- 8.2 Sexual Health -- 8.2.1 Impact of PCOS Traits on Sexual Function -- 8.2.2 General Impact of PCOS on Sexual Function -- 8.2.3 Androgens and Sexual Function in PCOS -- 8.3 Conclusions -- References -- 9: Infertility Management in Lean Versus Obese PCOS -- 9.1 Introduction -- 9.2 Pathophysiology of PCOS -- 9.2.1 Insulin Resistance and Hyperandrogenaemia -- 9.2.2 Obesity and Fertility -- 9.2.3 Obesity and Ovulatory Dysfunction -- 9.2.4 Lean Phenotype and Fertility. 9.2.5 Effect on Oocytes and Embryos -- 9.2.6 Effect on Endometrium -- 9.3 Management of Infertility -- 9.3.1 Lifestyle Modification in Obese PCOS -- 9.3.2 Lifestyle Modification in Lean PCOS -- 9.3.3 Bariatric Surgery -- 9.3.4 Anti-Obesity Drugs -- 9.4 Oral Contraceptive Pills (OCP) [31] -- 9.5 Ovulation Induction -- 9.5.1 Oral Ovulation Inducing Agents -- 9.5.2 Gonadotropins -- 9.5.3 GnRH Analogues -- 9.6 Laparoscopic Ovarian Drilling (LOD) -- 9.7 Assisted Reproductive Technologies (ART) -- 9.8 Insulin Sensitizers -- 9.8.1 Metformin -- 9.8.2 Inositols -- 9.8.3 Other Adjuvants -- 9.9 Psychological Intervention -- 9.9.1 Difference in Results between Obese and Lean PCOS -- 9.10 Preventing Complications -- 9.11 Conclusion -- References -- 10: Polycystic Ovary Syndrome: Fertility Treatment Options -- 10.1 Introduction -- 10.2 Fertility Treatment Options -- 10.2.1 Lifestyle Change for Weight Loss -- 10.2.2 Pharmacological and Surgical Ovulation Induction -- 10.2.2.1 Letrozole -- 10.2.2.2 Clomiphene Citrate -- 10.2.2.3 Metformin -- 10.2.2.4 Gonadotropins -- 10.2.2.5 Assisted Reproduction Technology -- 10.2.2.6 Ovarian Drilling -- 10.2.3 Other Treatment Options to Enhance Fertility -- 10.3 Selecting the Optimal Fertility Treatment Option -- 10.4 Conclusions -- References -- 11: Management of PCOS Women Preparing Pregnancy -- 11.1 Introduction -- 11.2 Pathophysiology of PCOS -- 11.3 Long-Term Consequences of PCOS -- 11.4 Treatment Targets -- 11.4.1 Lifestyle -- 11.4.2 Hyperandrogenism -- 11.4.3 Identifying Treatment Priorities in PCOS -- 11.4.4 Obesity -- 11.5 Insulin Resistance and Diabetes Mellitus -- 11.5.1 Decreased Fertility, Adverse Pregnancy Outcomes -- 11.6 Conclusion -- References -- 12: Impact of Polycystic Ovarian Syndrome, Metabolic Syndrome, and Obesity on Women's Health -- 12.1 Introduction. 12.2 Polycystic Ovarian Syndrome (PCOS) and Women's Health -- 12.2.1 PCOS and Fertility -- 12.2.2 PCOS and CVD Risk -- 12.2.3 PCOS and Depression -- 12.2.4 PCOS and Cancer Risk -- 12.3 Metabolic Syndrome (MetS) and Women's Health -- 12.3.1 MetS and Fertility -- 12.3.2 MetS and CVD Risk -- 12.3.3 MetS and Depression -- 12.4 Obesity: The Key Common Denominator in Women's Health -- 12.4.1 Obesity and Fertility -- 12.4.2 Obesity and Pregnancy -- 12.4.3 Obesity and Cancer Risk -- References -- 13: Pregnancy Outcome and Metabolic Syndrome -- 13.1 Introduction -- 13.2 Metabolic Syndrome, Obesity, and Pregnancy Complications -- 13.3 Inflammation, Insulin Resistance, and Oxidative Stress -- 13.4 Prevention of Adverse Obstetric Complications -- References -- 14: The Role of Insulin Resistance in Benign Breast Disease -- 14.1 Principles of Breast Endocrinology -- 14.2 Insulin -- 14.3 Benign Breast Disease -- 14.4 Benign Breast Disease and Breast Carcinoma -- 14.5 Conclusion -- References -- 15: Polycystic Ovary Syndrome and Inflammation -- 15.1 Introduction -- 15.2 Obesity and the PCOS -- 15.3 Inflammation and PCOS -- 15.3.1 Inflammation during Reproductive Life -- 15.3.2 Inflammation in Postmenopausal PCOS Women -- 15.4 Effect of Diet and Exercise on Inflammation -- 15.5 Effect of Probiotic and Synbiotic on Inflammation -- 15.6 Effect of Soy on Inflammation -- 15.7 Vitamin D Supplementation -- 15.8 Effect of Mineral Supplementation on Inflammation -- 15.9 Coenzyme Q10 Supplementation -- 15.10 Final Remarks -- References -- 16: Metabolic Changes at the Menopausal Transition -- 16.1 Introduction -- 16.2 Fat Distribution, Obesity, and Metabolic Syndrome (MS) -- 16.3 Relationship between Obesity, MS, and Menopausal Transition -- 16.3.1 Lipid Metabolism and Menopausal Transition. 16.3.2 The Management of Obesity and MS during Perimenopause -- 16.3.3 How to Prevent Weight Gain -- 16.4 Cardiovascular Disease and Menopause -- 16.5 Conclusions -- References -- 17: Cardiovascular Impact of Metabolic Abnormalities -- 17.1 Introduction -- 17.2 Lipids and Lipoproteins: What Happens in Menopause -- 17.3 Lipids and Lipoproteins: Effect of HRT on Lipids -- 17.4 Glucose: What Happens in Menopause -- 17.5 Glucose: Effect of HRT on Glucose -- 17.5.1 Hypertension: What Happens in Menopause -- 17.5.2 Hypertension: Effect of HRT on Hypertension -- 17.5.3 Obesity: What Happens in Menopause -- 17.5.4 Obesity: Effect on HRT on Weight -- 17.5.5 Inflammatory Markers: What Happens in Menopause -- 17.5.6 Inflammatory Markers: Effect of HRT on Inflammatory Markers -- 17.5.7 Vascular Function/VTE: What Happens in Menopause -- 17.6 Vascular Function/VTE: Effect of HRT on Vascular Function -- 17.7 Conclusion -- References -- 18: How to Prevent, Diagnose, and Treat Gynecological Cancer in PCO Patients? -- 18.1 Introduction -- 18.2 Endometrial Cancer Overview -- 18.3 Etiological and Molecular Mechanisms -- 18.4 Prevention of Endometrial Cancer -- 18.5 Place of Hormonal Prevention -- 18.5.1 Place of Weight Control -- 18.5.2 Place of Metformin -- 18.6 Diagnosis of Endometrial Hyperplasia and Cancer -- 18.7 Risk of Progression of Endometrial Hyperplasia -- 18.8 Treatment of Endometrial Hyperplasia and Cancer -- 18.8.1 Endometrial Hyperplasia -- 18.8.2 Endometrial Cancer -- 18.9 Conclusion -- References. |
| Record Nr. | UNINA-9910506384103321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel insights into the pathophysiology & treatment of PCOS / / editors, Evanthia Diamanti-Kandarakis, Shahla Nader, Dimitrios Panidis
| Novel insights into the pathophysiology & treatment of PCOS / / editors, Evanthia Diamanti-Kandarakis, Shahla Nader, Dimitrios Panidis |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London, England : , : Future Medicine Ltd., , [2012] |
| Descrizione fisica | 1 online resource (143 p.) |
| Disciplina | 618.11 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN | 1-78084-177-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Copyright page; Contents; Foreword. Novel insights into the pathophysiology and treatment of polycystic ovary syndrome; 1. Definition criteria and diagnostic assessments; 2. Pathogenesis; 3. Novel insights into the pathophysiology of PCOS: the role of environmental toxins; 4. Management of menstrual disorders and endometrial hyperplasia; 5. Polycystic ovary syndrome and fertility; 6. Appropriate use of metformin in early pregnancy: is there a role for first trimester use?; 7. Oral contraceptives: indications and cautions
8. Predictors of success and optimization of treatment in infertile PCOS patients9. Management of the metabolic syndrome and glucose intolerance in women with PCOS; 10. Polycystic ovary syndrome: prognosis and risk of comorbidity; Index |
| Altri titoli varianti | Novel insights into the pathophysiology and treatment of PCOS |
| Record Nr. | UNINA-9910787593403321 |
| London, England : , : Future Medicine Ltd., , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel insights into the pathophysiology & treatment of PCOS / / editors, Evanthia Diamanti-Kandarakis, Shahla Nader, Dimitrios Panidis
| Novel insights into the pathophysiology & treatment of PCOS / / editors, Evanthia Diamanti-Kandarakis, Shahla Nader, Dimitrios Panidis |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London, England : , : Future Medicine Ltd., , [2012] |
| Descrizione fisica | 1 online resource (143 p.) |
| Disciplina | 618.11 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN | 1-78084-177-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Copyright page; Contents; Foreword. Novel insights into the pathophysiology and treatment of polycystic ovary syndrome; 1. Definition criteria and diagnostic assessments; 2. Pathogenesis; 3. Novel insights into the pathophysiology of PCOS: the role of environmental toxins; 4. Management of menstrual disorders and endometrial hyperplasia; 5. Polycystic ovary syndrome and fertility; 6. Appropriate use of metformin in early pregnancy: is there a role for first trimester use?; 7. Oral contraceptives: indications and cautions
8. Predictors of success and optimization of treatment in infertile PCOS patients9. Management of the metabolic syndrome and glucose intolerance in women with PCOS; 10. Polycystic ovary syndrome: prognosis and risk of comorbidity; Index |
| Altri titoli varianti | Novel insights into the pathophysiology and treatment of PCOS |
| Record Nr. | UNINA-9910816861903321 |
| London, England : , : Future Medicine Ltd., , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polycystic ovarian syndrome / / edited by Zhengchao Wang
| Polycystic ovarian syndrome / / edited by Zhengchao Wang |
| Pubbl/distr/stampa | London, United Kingdom : , : IntechOpen, , [2020] |
| Descrizione fisica | 1 online resource (160 pages) : illustrations |
| Disciplina | 618.11 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN | 1-83880-290-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910409730103321 |
| London, United Kingdom : , : IntechOpen, , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polycystic Ovarian Syndrome / / edited by Zhengchao Wang
| Polycystic Ovarian Syndrome / / edited by Zhengchao Wang |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2020 |
| Descrizione fisica | 1 online resource (160 pages) |
| Disciplina | 618.11 |
| Soggetto topico | Polycystic ovary syndrome |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910688319203321 |
| London : , : IntechOpen, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polycystic Ovary Syndrome : Functional Investigation and Clinical Application / / edited by Zhengchao Wang
| Polycystic Ovary Syndrome : Functional Investigation and Clinical Application / / edited by Zhengchao Wang |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (178 pages) |
| Disciplina | 618.11 |
| Soggetto topico | Polycystic ovary syndrome |
| ISBN | 1-80355-382-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Pathophysiology of Polycystic Ovarian Syndrome. 2. Thyroid Dysfunction: In Connection with PCOS. 3. Polycystic Ovary Syndrome: It's Not Just Infertility. 4. Rare and Underappreciated Causes of Polycystic Ovarian Syndrome. 5. Special Considerations on Hyperandrogenism and Insulin Resistance in Nonobese Polycystic Ovaries Syndrome. 6. Novel Methods in the Diagnosis of PCOS: The Role of 3D Ultrasonographic Modalities. 7. The Novelty of miRNAs as a Clinical Biomarker for the Management of PCOS. 8. Role of Oxidative Stress and Carnitine in PCOS Patients. 9. Polycystic Ovary Syndrome Phenotypes and Infertility Treatment. |
| Altri titoli varianti | Polycystic Ovary Syndrome |
| Record Nr. | UNINA-9910633978103321 |
| London : , : IntechOpen, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
